A randomized controlled clinical trial of metformin in preventing recurrence and carcinogenesis after endoscopic removal of colorectal adenoma
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
Interventions: Metformin group 1:Metformin 250mg / day Oral;Metformin group 2:Metformin 250mg / day Oral;Control group:Placebo Primary outcome(s): Colorectal adenoma recurrence rate Study Design: Parallel
创建时间：
2020-08-15
